Profitability Ratios
| Ratio |
Value |
| GP Margin |
87.9% |
| EBIT Margin |
54.5% |
| EBITDA Margin |
57.2% |
| Operating Margin |
47.7% |
| Pretax Margin |
53.9% |
| Cont. Ops Margin |
41.9% |
| Net Margin |
41.9% |
| Bottom Line Margin |
41.9% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
6.60 |
| Quick Ratio |
6.28 |
| Solvency Ratio |
1.812 |
| Cash Ratio |
2.78 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
1.16 |
| Forward PEG |
1.16 |
| Price/Book |
3.04 |
| Price/Sales |
6.78 |
| Price/FCF |
20.74 |
| Price/Op Cash Flow |
13.83 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.0000 |
| Debt/Equity |
0.0000 |
| Debt/Capital |
0.0000 |
| Long-Term Debt/Capital |
0.0000 |
| Financial Leverage |
1.11 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
1.01 |
| Operating Cash Flow Ratio |
2.785 |
| Operating Cash Flow/Sales |
49.1% |
| Free Cash Flow/Operating Cash Flow |
66.7% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
73.84 |
| Interest Coverage |
77.8051 |
| Short-Term Operating Cash Flow Coverage |
0.00 |
| Operating Cash Flow Coverage |
0.00 |
| Capital Expenditure Coverage |
3.00 |
| Dividend + Capital Expenditure Coverage |
3.00 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
71.84 |
| EPS |
30.129 |
| Debt/Share |
0.4402 |
| Cash/Share |
35.15 |
| Book Value/Share |
160.19 |
| Tangible BV/Share |
157.56 |
| Equity/Share |
160.19 |
| Operating Cash Flow/Share |
35.242 |
| Capital Expenditure/Share |
11.749 |
| FCF/Share |
23.492 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.779 |
| Earnings Before Tax/EBIT |
1.130 |
| Price/Fair Value |
3.04 |
| Debt/Market Cap |
0.0000 |
| Effective Tax Rate |
22.1% |
| Enterprise Value Multiple |
11.01 |
UTHR - United Therapeutics Corporation